Type H vessels—a bridge connecting subchondral bone remodelling and articular cartilage degeneration in osteoarthritis development

Abstract Recent studies have shed light on the cellular and molecular mechanisms that link subchondral bone remodelling and angiogenesis in knee osteoarthritis (OA). Type H vessels are a newly identified bone blood vessel characterized by high expression of CD31 and endomucin that are coupled with o...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 62; no. 4; pp. 1436 - 1444
Main Authors Liu, Yuan, Xie, Hui-Qi, Shen, Bin
Format Journal Article
LanguageEnglish
Published England Oxford University Press 03.04.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Recent studies have shed light on the cellular and molecular mechanisms that link subchondral bone remodelling and angiogenesis in knee osteoarthritis (OA). Type H vessels are a newly identified bone blood vessel characterized by high expression of CD31 and endomucin that are coupled with osteogenesis. Factors including mechanical loading, TGF-β1, platelet-derived growth factor type BB, the osteoprotegerin–RANK ligand–RANK system, osteopontin, mechanistic target of rapamycin, VEGF, stromal cell-derived factor l and prostaglandin E2 participate in the formation of type H vessels in osteoarthritic subchondral bone. In this review, we summarize the current understanding of type H vessels in knee OA, as well as the signalling pathways involved and potential therapeutic medicines. In future, the pathogenesis of knee OA could be further clarified by connecting type H vessels and the design of new disease-modifying osteoarthritis drugs. However, further experiments are needed to determine the upstream signals regulating type H vessel formation in osteoarthritic subchondral bone.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1462-0324
1462-0332
1462-0332
DOI:10.1093/rheumatology/keac539